• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TYVASO INHALATION SYSTEM - NEBULIZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TYVASO INHALATION SYSTEM - NEBULIZER Back to Search Results
Model Number TD-100/A
Device Problems Output above Specifications (1432); Inaccurate Delivery (2339); Device Operates Differently Than Expected (2913)
Patient Problems Headache (1880); Overdose (1988)
Event Type  Injury  
Event Description
Device continues to produce vapor [device issue].Received too much medication [incorrect dose administered by device].Lightheadedness.Case description: this case is a spontaneous report from the united states received from a consumer via a specialty pharmacy on 03/02/2016.The patient was a (b)(6), (b)(6), male of unreported height and race, who first received tyvaso (treprostinil) via inhalation route on (b)(6) 2015 for secondary pulmonary hypertension.Inhaled (ih) treprostinil dosage was 18-54 micrograms (3-9 breaths), four times a day, at the time of the events.Inhaled treprostinil was delivered via tyvaso inhalation system, model td-100/a, serial number (b)(4).The patient was on the following concomitant medications at the time of the events: sildenafil and letairis (ambrisentan).On an unspecified date in 2016, the patient's device produced vapor/mist even when the patient was not inhaling, which lead to the patient receiving too much medication.Approximately 30 minutes post treatment, the patient had lightheadedness which lasted for about an hour and then abated.The patient felt much better when he used an alternate device.Patient reports device was continuously producing vapor/mist causing the patient to receive too much drug output.The specialty pharmacy confirmed the devices were replaced.The investigation is incomplete at the time of this report.Mfr name, city and state: (b)(4).Initial reporter: name, address and telephone number withheld.Device manufacture date: 07/2014.Mfr#: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TYVASO INHALATION SYSTEM - NEBULIZER
Type of Device
NEBULIZER
MDR Report Key5553784
MDR Text Key42211969
Report NumberMW5061523
Device Sequence Number1
Product Code CAF
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other
Type of Report Initial
Report Date 03/02/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberTD-100/A
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer03/29/2016
Is the Reporter a Health Professional? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age31 YR
Patient Weight68
-
-